Robert G. Savage

Robert G. Savage has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Medicines Co /DE, Immune Pharmaceuticals Inc and Noven Pharmaceuticals Inc. We count 68 filings; the first trade dates from 23 May 2006 and the latest from 14 May 2019.

On the open market, the record shows 26 purchases worth €75k and 10 sales worth €1.9M. The net balance comes to €1.8M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 21 share grants and 8 option exercises.

A typical purchase (the median) is worth €2,673.

The newest entry dates from 16 May 2019: a share grant of €59k, in Humanigen, Inc. The clock since the last published purchase (14 December 2007) now reads 6,889 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.